GGrantIndex
Sort

50,496 grants matching lung cancer

Training in Comparative Lung Biology and Medicine

$437,199
Reen Wu · University Of California At Davis · T32 · FY2015 · HL

RCT of An Internet Cessation Program Plus Online Social Network for HIV + Smokers

$437,199
Jonathan Shuter · Albert Einstein College Of Medicine, Inc · R01 · FY2018 · CA

Novel Regulation of the Activation and Assembly of the Heterimeric Receptor Tyrosine Kinase Complexes for Cell Signaling

$437,152
Hong Sun · University Of Nevada Las Vegas · R15 · FY2020 · CA

TOBACCO AND CANCER RISK--DOSE, METABOLISM AND GENETICS

$437,114
Institute For Cancer Prevention · P01 · FY2004 · CA

MEK AND PI3K INHIBITION IN THE REGULATION OF PANCREATIC CANCER METABOLISM

$437,090
Lewis C Cantley · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA

Developmental transcription factors in Drosha-driven cancer

$437,063
Kenneth Sung-Man Chen · Ut Southwestern Medical Center · R01 · FY2025 · CA

Molecular origins and impact of APOBEC3 mutagenesis in cancer

$437,025
John Maciejowski · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA

ROLE OF Rac AND REACTIVE OXYGEN SPECIES IN KAPOSI'S SARCOMA VIRAL ONCOGENESIS

$437,003
Enrique A Mesri · University Of Miami School Of Medicine · R01 · FY2012 · CA

Neu5Gc and anti-Neu5Gc antibodies for detection of cancer and cancer risk

$436,949
Ajit P Varki · University Of California, San Diego · U01 · FY2007 · CA

The Role of Akt in Cell Survival and Cell Growth

$436,935
Nissim Hay · University Of Illinois At Chicago · R01 · FY2015 · AG

Mechanisms by which LSD1 Promotes Neuroendocrine Differentiation and Small Cell Lung Cancer

$436,924
Matthew Gilbert Oser · Dana-Farber Cancer Inst · R37 · FY2024 · CA

Whole Genome Amplification and Sequencing of Single Cancer Cells

$436,919
Xiaoliang Sunney Xie · Harvard University · R33 · FY2013 · CA

Reposition and Optimization of Deferiprone for Breast Cancer Therapy

$436,894
Adegboyega Oyelere · Georgia Institute Of Technology · R01 · FY2022 · CA

Dissecting and targeting PAK4 in Ewing sarcoma

$436,850
Jason Yustein · Emory University · R01 · FY2024 · CA

NextGen RNAi Delivery to Breast Tumors for Selective mTORC2 Blockade

$436,809
Craig Lewis Duvall · Vanderbilt University · R01 · FY2019 · CA

Proj 4: Triggers for the Induction of T Cell Dysfunction on T cells in Glioblastoma

$436,798
Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2023 · CA

Proj 4: Triggers for the Induction of T Cell Dysfunction on T cells in Glioblastoma

$436,798
Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2022 · CA

Developing an Effective BET bromodomain inhibitor Drug Combo to Target SCLC

$436,781
Haobin Chen · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Predictive biomarker of BET bromodomain inhibitor in Small cell lung cancer

$436,781
Haobin Chen · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Development of Advanced C-arm Cone-Beam CT for the Treatment of Liver Cancer

$436,757
Xiaochuan Pan · University Of Chicago · R01 · FY2017 · CA

Skin & Immunology - Mitigation of Radiation and Combined Injury to the Skin

$436,752
Edith M. Lord · University Of Rochester · U19 · FY2012 · AI

Using CBPR to Implement Smoking Cessation in an Urban American Indian Community

$436,724
Christine Makosky Daley · University Of Kansas Medical Center · R24 · FY2009 · MD

Functional Determinants of Metastatic Dormancy

$436,677
Julio A Aguirre-Ghiso · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · CA

Chip-Based Diagnosis of Problematic Liver Tumors

$436,661
Timothy J Yeatman · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2010 · CA

Tubulin microtentacles in detached mammary epithelial cells

$436,628
Stuart S Martin · University Of Maryland Baltimore · R01 · FY2019 · CA